Medicine
Teriparatide 560 mcg/2.24 mL injection
Teriparatide 560 mcg/2.24 mL injection is a generic prescription medicine for subcutaneous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store Teriparatide Injection under refrigeration at 2° to 8°C (36° to 46°F) at…
Key facts
- Active ingredient (INN)
- Teriparatide
- Brand
- Sold under the generic name
- Strength
- 560 mcg/2.24 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe of 2.24 mL and 4 more
- Manufacturers
- Prasco LaboratoriesAlvogenAmphastar PharmaceuticalsApotexBluePoint LaboratoriesTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store Teriparatide Injection under refrigeration at 2° to 8°C (36° to 46°F) at all times except when administering the product. When using Teriparatide Injection, minimize the time out of the refrigerator, deliver the dose immediately following removal from the refrigerator. Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H05AA02 Teriparatide
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 November 2019
- Identifiers
- RxCUI 1435115DailyMed set ID ab322675-4769-45b0-b146-14fbaa3135d0, d371f0f7-d492-4481-b360-051456d56d65, 1b007339-dd0d-f019-5e0a-9b1b0f75011c +3NDC 66993-989, 0093-1106, 47781-652 +4Application NDA021318, ANDA208569, NDA211939 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe in 1 carton / 2.24 mL in 1 syringe | 47781-652-89 | Alvogen | 14 November 2019 |
| 1 syringe in 1 carton / 2.24 mL in 1 syringe | 0548-2311-00 | Amphastar Pharmaceuticals | 22 December 2025 |
| 1 syringe in 1 carton / 2.24 mL in 1 syringe | 60505-6188-0 | Apotex | 17 November 2023 |
| 1 syringe in 1 carton / 2.24 mL in 1 syringe | 0093-1106-16 | Teva Pharmaceuticals | 18 December 2023 |
| 1 syringe in 1 carton / 2.24 mL in 1 syringe | 66993-495-28 | Prasco Laboratories | 17 November 2023 |
| 1 syringe in 1 carton / 2.24 mL in 1 syringe | 66993-989-28 | Prasco Laboratories | 16 June 2025 |
| 1 syringe in 1 carton / 2.24 mL in 1 syringe | 68001-693-76 | BluePoint Laboratories | 19 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Teriparatide 560 mcg/2.24 mL injection.
Clinical summary
Teriparatide is a parathyroid hormone analog indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture). MedsAcross supplies Teriparatide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TeriparatideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Forteo prescribing information (Eli Lilly) · U.S. National Library of Medicine, DailyMed
- Forsteo: European public assessment report (EPAR) · European Medicines Agency
- Teriparatide Sun: European public assessment report (EPAR) · European Medicines Agency
Need Teriparatide 560 mcg/2.24 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.